Evidence map›Paper›PMID 39359937›Full record

ReviewFrontiers in cellular and infection microbiology2024

Recent advancement of novel marine fungi derived secondary metabolite fibrinolytic compound FGFC in biomedical applications: a review.

Lakshmi Jeevithan, Xiaozhen Diao, Jiudong Hu, Jeevithan Elango, Wenhui Wu, Jose Eduardo Mate Sanchez de Val, Saravanan Rajendran, Thanigaivel Sundaram, Suresh Kumar Rajamani Sekar

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lakshmi JeevithanDepartment of Marine Biopharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai, China.
Xiaozhen DiaoDepartment of Marine Biopharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai, China.
Jiudong HuShanghai Sixth People's Hospital, affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jeevithan ElangoDepartment of Marine Biopharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai, China.
Wenhui WuDepartment of Marine Biopharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai, China.
Jose Eduardo Mate Sanchez de ValDepartment of Biomaterials Engineering, Faculty of Health Sciences, UCAM-Universidad Catolica San-Antonio de Murcia, Murcia, Spain.
Saravanan RajendranInstituto de Alta Investigacion, Universidad de Tarapacá, Arica, Chile.
Thanigaivel SundaramDepartment of Biotechnology, Faculty of Science & Humanities, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India.
Suresh Kumar Rajamani SekarCollege of Natural Sciences, Arba Minch University, SNNPR, Arba Minch, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For several decades, products derived from marine natural sources (PMN) have been widely identified for several therapeutic applications due to their rich sources of bioactive sub-stances, unique chemical diversity, biocompatibility and excellent biological activity. For the past 15 years, our research team explored several PMNs, especially fungi fibrinolytic compounds (FGFCs). FGFC is an isoindolone alkaloid derived from marine fungi, also known as staplabin analogs or

Indexed as

Aquatic OrganismsStachybotrysAlkaloidsAnimalsBiological ProductsFibrinolytic AgentsFungiHumansSecondary MetabolismAlkaloidsBiological ProductsFibrinolytic Agentsantithrombotic activitiesbiomedical applicationsfungi fibrinolytic compoundsmarine metabolitessignaling mechanism

Identifiers

PMID39359937
PMCPMC11445226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.